Anbio Biotechnology Class A Ordinary Shares Profit Margin

Anbio Biotechnology Class A Ordinary Shares's profit margin stands at 50.09% as of December 2025. That is above the sector sector average of 13.2%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Anbio Biotechnology Class A Ordinary Shares sits higher the its sector benchmark (13.2%) with a profit margin of 50.09%. That is roughly 279.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 50.09% for Anbio Biotechnology Class A Ordinary Shares means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Anbio Biotechnology Class A Ordinary Shares's profit margin evolved across reporting periods, while the comparison chart places NNNN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.